Intersect ENT announces FDA approval of newest steroid releasing implant, PROPEL(R)
Intersect ENT announced the company has received approval from the FDA for its PROPEL® Contour steroid releasing sinus implant. PROPEL Contour features an innovative hourglass design that facilitates treatment of patients with chronic sinusitis in the frontal and maxillary sinuses. February 24, 2017